NCT01559116 - Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

219

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

tiotropium + olodaterol

low dose + one dose only

DRUG

tiotropium

low dose

DRUG

olodaterol

one dose only

DRUG

tiotropium

high dose

DRUG

tiotropium + olodaterol

low dose + one dose only

DRUG

Placebo

placebo matching tiotropium+olodaterol FDC

DEVICE

Respimat

Respimat inhaler

Trial Locations (29)

Unknown

1237.20.1204 Boehringer Ingelheim Investigational Site, Jasper

1237.20.1203 Boehringer Ingelheim Investigational Site, Easley

1237.20.1201 Boehringer Ingelheim Investigational Site, Greenville

1237.20.1202 Boehringer Ingelheim Investigational Site, Spartanburg

1237.20.32203 Boehringer Ingelheim Investigational Site, Genk

1237.20.32201 Boehringer Ingelheim Investigational Site, Ghent

1237.20.32204 Boehringer Ingelheim Investigational Site, Jambes

1237.20.02202 Boehringer Ingelheim Investigational Site, Québec

1237.20.02201 Boehringer Ingelheim Investigational Site, Sherbrooke

1237.20.45002 Boehringer Ingelheim Investigational Site, Hvidovre

1237.20.45003 Boehringer Ingelheim Investigational Site, Odense C

1237.20.45001 Boehringer Ingelheim Investigational Site, Silkeborg

1237.20.49205 Boehringer Ingelheim Investigational Site, Berlin

1237.20.49204 Boehringer Ingelheim Investigational Site, Großhansdorf

1237.20.49203 Boehringer Ingelheim Investigational Site, Hamburg

1237.20.49206 Boehringer Ingelheim Investigational Site, Hamburg

1237.20.49201 Boehringer Ingelheim Investigational Site, Mannheim

1237.20.49207 Boehringer Ingelheim Investigational Site, Mönchengladbach

1237.20.49202 Boehringer Ingelheim Investigational Site, Wiesbaden

1237.20.36202 Boehringer Ingelheim Investigational Site, Gödöllö

1237.20.36204 Boehringer Ingelheim Investigational Site, Komárom

1237.20.36203 Boehringer Ingelheim Investigational Site, Pécs

1237.20.36201 Boehringer Ingelheim Investigational Site, Szarvas

1237.20.36205 Boehringer Ingelheim Investigational Site, Százhalombatta

1237.20.31205 Boehringer Ingelheim Investigational Site, Almelo

1237.20.31202 Boehringer Ingelheim Investigational Site, Breda

1237.20.31201 Boehringer Ingelheim Investigational Site, Heerlen

1237.20.31204 Boehringer Ingelheim Investigational Site, Hengelo

1237.20.31203 Boehringer Ingelheim Investigational Site, Zutphen